Foghorn Therapeutics Inc. (FHTX) Net margin 2020–2025
Foghorn Therapeutics Inc. (FHTX) net profit margin by fiscal year — reported net income divided by reported revenue.
-240.3%FY2025 · since FY2020: -16000.0% → -240.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -240.3% | +142.9 pp |
| FY2024 | -383.2% | -95.1 pp |
| FY2023 | -288.2% | +278.1 pp |
| FY2022 | -566.3% | +7115.3 pp |
| FY2021 | -7681.6% | +8318.4 pp |
| FY2020 | -16000.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice